Jens Grueger PhD, MSc

Jens Grueger, Ph.D. is a Director and Partner at Boston Consulting Group in Zurich, Switzerland where he is the senior expert for pricing and market access in the life sciences. Previously, Dr. Grueger was Head of Global Access at F. Hoffmann-La Roche, based in Basel, Switzerland. With his team, they drove holistic access strategies to ensure that Roche and healthcare systems deliver rapid, broad, and sustainable patient access to the company’s innovative offerings. Jens was trained in mathematics and medicine, receiving a master’s degree in medical statistics (1984) and a Ph.D. in theoretical statistics (1986) from the Technical University of Dortmund in Germany. He started his professional career as a health systems researcher, consulting with governments and payers (1986-1994).

He led the country, regional, and global health economics and outcomes research, pricing, and access organizations for SmithKline Beecham (1994-1999), Novartis (1999-2009), Pfizer (2009-2011), and Roche (2011-2019). He built on the principles of health economics when driving value-based pricing in order to accelerate and broaden access for patients to innovative medicines. He has been promoting risk-sharing, performance-based pricing, indication-based pricing, and international differential pricing. He has been leading innovative projects to engage with health technology assessment, payers, and patients around scientific advice, joint clinical scientific assessment, and innovative approaches to evidence generation including real-world data.